Jan-Gunnar Gustafsson, VP of Process Development and Manufacturing, Baau Therapeutics Speaks to Pharma IQ




Jan-Gunnar Gustafsson Vice President, Process Development and Manufacturing, Baau Therapeutics AB, speaks to Andrea Charles from Pharma IQ, about contract manufacturing strategy, mitigating risk and approaches to CMO selection from a small biotech perspective, at Pharma IQ's Global Pharmaceutical Contract Manufacturing Conference for Pharma and Bio in June 2011. Gustafsson also shares his insights on the challenges that you face when outsourcing from a small company and how to effectively gain the interest of a CMO and create negotiation power.

 

As the pharmaceutical industry relies on faster drug development and cost containment to maintain growth, there has never been a more important time to develop strategic CMO alliances to facilitate entry into emerging markets, reduce costs and increase product revenue.  But with so many CMOs to choose from, how can you guarantee that you have the right partner to provide the services you require with minimal risk and maximum efficiency?

[eventpdf]

Jan-Gunnar Gustafsson Vice President, Process Development and Manufacturing, Baau Therapeutics AB, speaks to Andrea Charles from Pharma IQ, about contract manufacturing strategy, mitigating risk and approaches to CMO selection from a small biotech perspective, at Pharma IQ's Global Pharmaceutical Contract Manufacturing Conference for Pharma and Bio in June 2011. Gustafsson also shares his insights on the challenges that you face when outsourcing from a small company and ...
TO READ THE FULL STORY